A detailed history of Vanguard Group Inc transactions in Avita Medical, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,395,701 shares of RCEL stock, worth $15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,395,701
Previous 1,408,136 0.88%
Holding current value
$15 Million
Previous $22.6 Million 51.03%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$7.92 - $15.55 $98,485 - $193,364
-12,435 Reduced 0.88%
1,395,701 $11.1 Million
Q1 2024

May 10, 2024

BUY
$12.56 - $18.31 $192,871 - $281,168
15,356 Added 1.1%
1,408,136 $22.6 Million
Q4 2023

Feb 14, 2024

BUY
$9.29 - $14.57 $298,060 - $467,463
32,084 Added 2.36%
1,392,780 $19.1 Million
Q3 2023

Nov 14, 2023

BUY
$13.84 - $20.79 $153,098 - $229,978
11,062 Added 0.82%
1,360,696 $19.9 Million
Q2 2023

Aug 14, 2023

BUY
$10.7 - $17.48 $1.54 Million - $2.51 Million
143,802 Added 11.93%
1,349,634 $23 Million
Q1 2023

May 15, 2023

BUY
$6.45 - $14.48 $370,913 - $832,686
57,506 Added 5.01%
1,205,832 $16.8 Million
Q4 2022

Feb 10, 2023

BUY
$4.53 - $7.55 $2,586 - $4,311
571 Added 0.05%
1,148,326 $7.58 Million
Q2 2022

Aug 12, 2022

SELL
$4.6 - $8.82 $594,421 - $1.14 Million
-129,222 Reduced 10.12%
1,147,755 $5.45 Million
Q1 2022

May 13, 2022

BUY
$6.96 - $12.15 $45,010 - $78,574
6,467 Added 0.51%
1,276,977 $10.8 Million
Q4 2021

Feb 14, 2022

BUY
$11.72 - $19.66 $100,346 - $168,328
8,562 Added 0.68%
1,270,510 $15.2 Million
Q3 2021

Nov 12, 2021

SELL
$16.73 - $20.9 $561,174 - $701,048
-33,543 Reduced 2.59%
1,261,948 $22.4 Million
Q2 2021

Aug 13, 2021

BUY
$17.23 - $22.02 $22.3 Million - $28.5 Million
1,295,491 New
1,295,491 $26.6 Million

Others Institutions Holding RCEL

About AVITA Medical, Inc.


  • Ticker RCEL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,030,900
  • Market Cap $269M
  • Description
  • AVITA Medical Inc. operates as a commercial-stage regenerative tissue company in the United States, Australia, and the United Kingdom. It offers regenerative products to address unmet medical needs in burn injuries, trauma injuries, chronic wounds, and dermatological and aesthetics indications, including vitiligo. The company's patented and prop...
More about RCEL
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.